Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 9.76
- Piotroski Score 6.00
- Grade Neutral
- Symbol (EW)
- Company Edwards Lifesciences Corporation
- Price $65.84
- Changes Percentage (0.14%)
- Change $0.09
- Day Low $65.26
- Day High $66.33
- Year High $96.12
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/03/2025
- Fiscal Year End N/A
- Average Stock Price Target $80.00
- High Stock Price Target $140.00
- Low Stock Price Target $66.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.32
- Trailing P/E Ratio 37.99
- Forward P/E Ratio 37.99
- P/E Growth 37.99
- Net Income $1.40 B
Income Statement
Quarterly
Annual
Latest News of EW
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Mar-a-Lago, other Palm Beach County properties send Trump's new tax bills higher
Donald Trump's Mar-a-Lago Club in Palm Beach generates significant property taxes, contributing over $2 million in 2024. The tax bills for Trump's properties in the county increased by 11.5%, reflecti...
By Yahoo! Finance | 1 hour ago -
Lewis Hall England call-up a 'great achievement for someone so young' - Eddie Howe
Lewis Hall, a rising talent, has impressed at Newcastle this season after a slow start. His commitment and hard work are paying off, leading to a successful transition to left-back. Tino Livramento is...
By The New York Times | 1 hour ago -
I grew my business to 7 figures after leaving Meta and Google. Here's the coffee chat formula that helped.
Successful networking involves building 1:1 relationships through activities like coffee chats. Preparing well, being genuine, and offering value can help leverage these interactions to build connecti...
By Business Insider | 1 hour ago
